---
title: "Trend — cq10 600mg softgels - Flapen"
canonical_url: "https://flapen.com/research/us/health-household/cq10-600mg-softgels/trend"
last_updated: "2026-08-11T10:42:36.056Z"
locale: en
meta:
  description: "Niche score 50/100 · $65K/yr market · 22K searches/yr · $35.68 avg price. A small market ($65K/yr) keeps it on the watch list. Data updated Jul 2026."
  "og:description": "Niche score 50/100 · $65K/yr market · 22K searches/yr · $35.68 avg price. A small market ($65K/yr) keeps it on the watch list. Data updated Jul 2026."
  "og:title": "Trend — cq10 600mg softgels - Flapen"
---

# **cq10 600mg softgels**

**Worth a look**

Shows low returns (0.0%), but a small market ($65K/yr) keeps it on the watch list.

Market size 16Growth 66Conversion 80Competition 27Returns 100Price range 43Avg price 95Brand share 52Review moat 25Quality gap 23

**Returns**

**Incredible****0.0%**

return rate — above 5% kills the launch gate

**Avg price**

**Incredible****$35.68**

avg listing price — sweet spot $15–$100

**Conversion**

**Great****8.4%**

search→purchase rate — share of searches ending in a sale

**Growth**

**Good****+45.7%**

90-day search growth — must beat 0% to launch

**Brand share**

**Good****74%**

top-5 brand share — brands hold most of the demand

**Price range**

**Okay****$10.16–$206.62**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Competition**

**Okay****69%**

top-5 click share — leaders hold, buyers still browse

**Review moat**

**Bad****4,644.8**

avg incumbent reviews — the moat a new listing must climb

**Quality gap**

**Bad****4.6★**

avg incumbent rating — lower means beatable quality

**Market size**

**Bad****$65K**

$65K/yr · 22K searches

## Trend